ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GREGG OSTERGREN DO

Internal Medicine

17,522

$1.14M

661
595 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $56

RANDI LEGGETT MD

Internal Medicine

2,897

$226K

285
279 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$78
Average prescription price

Avg: $56

ELLEN KIM MD

Internal Medicine

14,842

$670K

540
425 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $56

BRIAN SEPPI MD

Internal Medicine

8,478

$443K

380
337 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

TIMOTHY TROEH M.D.

Internal Medicine

22,098

$1.05M

735
623 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

RANU CHOUDHARY MD

Internal Medicine

11,942

$671K

365
338 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $56

RICO ROMANO MD

Internal Medicine

8,577

$416K

564
445 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

ROMIL WADHAWAN MD

Internal Medicine

10,448

$517K

584
484 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

SU YONG PAK M.D.

Internal Medicine

15,201

$939K

547
507 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

PEGGY BISSELL MD

Internal Medicine

6,885

$444K

412
336 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $56

STANLEY LING MD

Internal Medicine

7,342

$546K

357
297 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$74
Average prescription price

Avg: $56

JOANNE LYNN PEREZ M.D.

Internal Medicine

8,920

$444K

360
332 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

21%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $56

CHARLES NAM MD

Internal Medicine

10,069

$660K

520
407 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $56

SHWETA BALIGA MD

Internal Medicine

14,770

$838K

520
431 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $56

TEACKLE MARTIN MD

Internal Medicine

7,859

$374K

497
421 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

LUBNA KHAN MD

Internal Medicine

12,677

$628K

527
494 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $56

SANJIT DUTTA MD

Internal Medicine

13,429

$614K

645
527 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

ALEXANDER MIHALI MD

Internal Medicine

10,767

$489K

438
398 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $56

STEWART BIRSE MD

Internal Medicine

13,550

$643K

537
450 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

MICHAEL HERRING MD

Internal Medicine

10,794

$381K

452
417 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 23%

$35
Average prescription price

Avg: $56

ANNA MADEJ M. D.

Internal Medicine

9,379

$453K

368
325 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

ROBERT WIGERT MD

Internal Medicine

11,351

$534K

476
397 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

LINDA STRONG M.D.

Internal Medicine

14,117

$722K

801
736 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

JONG-WOOK BAN M.D.

Internal Medicine

9,411

$565K

566
436 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $56

JOHANN BERNARDO MD

Internal Medicine

9,793

$583K

545
423 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank